EF-022
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EF-022, covering 2016-08-03 to 2017-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors [Phase 1]